QQQ   418.99 (-1.04%)
AAPL   165.24 (-1.08%)
MSFT   402.14 (-0.53%)
META   488.94 (-2.56%)
GOOGL   154.88 (-0.72%)
AMZN   176.24 (-1.66%)
TSLA   149.67 (-0.17%)
NVDA   823.50 (-2.74%)
AMD   150.42 (-3.00%)
NIO   3.86 (-3.50%)
BABA   68.88 (+0.00%)
T   16.28 (-0.31%)
F   12.12 (+0.50%)
MU   108.10 (-3.42%)
GE   150.83 (-1.38%)
CGC   7.78 (-0.64%)
DIS   111.89 (-0.48%)
AMC   3.10 (+6.16%)
PFE   25.73 (+1.34%)
PYPL   62.09 (-0.02%)
XOM   120.18 (+1.40%)
QQQ   418.99 (-1.04%)
AAPL   165.24 (-1.08%)
MSFT   402.14 (-0.53%)
META   488.94 (-2.56%)
GOOGL   154.88 (-0.72%)
AMZN   176.24 (-1.66%)
TSLA   149.67 (-0.17%)
NVDA   823.50 (-2.74%)
AMD   150.42 (-3.00%)
NIO   3.86 (-3.50%)
BABA   68.88 (+0.00%)
T   16.28 (-0.31%)
F   12.12 (+0.50%)
MU   108.10 (-3.42%)
GE   150.83 (-1.38%)
CGC   7.78 (-0.64%)
DIS   111.89 (-0.48%)
AMC   3.10 (+6.16%)
PFE   25.73 (+1.34%)
PYPL   62.09 (-0.02%)
XOM   120.18 (+1.40%)
QQQ   418.99 (-1.04%)
AAPL   165.24 (-1.08%)
MSFT   402.14 (-0.53%)
META   488.94 (-2.56%)
GOOGL   154.88 (-0.72%)
AMZN   176.24 (-1.66%)
TSLA   149.67 (-0.17%)
NVDA   823.50 (-2.74%)
AMD   150.42 (-3.00%)
NIO   3.86 (-3.50%)
BABA   68.88 (+0.00%)
T   16.28 (-0.31%)
F   12.12 (+0.50%)
MU   108.10 (-3.42%)
GE   150.83 (-1.38%)
CGC   7.78 (-0.64%)
DIS   111.89 (-0.48%)
AMC   3.10 (+6.16%)
PFE   25.73 (+1.34%)
PYPL   62.09 (-0.02%)
XOM   120.18 (+1.40%)
QQQ   418.99 (-1.04%)
AAPL   165.24 (-1.08%)
MSFT   402.14 (-0.53%)
META   488.94 (-2.56%)
GOOGL   154.88 (-0.72%)
AMZN   176.24 (-1.66%)
TSLA   149.67 (-0.17%)
NVDA   823.50 (-2.74%)
AMD   150.42 (-3.00%)
NIO   3.86 (-3.50%)
BABA   68.88 (+0.00%)
T   16.28 (-0.31%)
F   12.12 (+0.50%)
MU   108.10 (-3.42%)
GE   150.83 (-1.38%)
CGC   7.78 (-0.64%)
DIS   111.89 (-0.48%)
AMC   3.10 (+6.16%)
PFE   25.73 (+1.34%)
PYPL   62.09 (-0.02%)
XOM   120.18 (+1.40%)
Free Trial

ORIC Pharmaceuticals (ORIC) Earnings Date, Estimates & Call Transcripts

→ New crypto project uncovers 2,050% in 65 days (From InvestorPlace) (Ad)
Free ORIC Stock Alerts
$9.15
-0.36 (-3.79%)
(As of 11:14 AM ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability

Earnings Summary

Upcoming
Earnings Date
May. 13Estimated
Actual EPS
(Mar. 11)
-$0.49
Consensus EPS
(Mar. 11)
-$0.49
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

ORIC Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ORIC Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

ORIC Pharmaceuticals Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20242($0.46)($0.43)($0.45)
Q2 20242($0.43)($0.43)($0.43)
Q3 20242($0.44)($0.44)($0.44)
Q4 20242($0.46)($0.46)($0.46)
FY 20248($1.79)($1.76)($1.78)

ORIC Earnings Date and Information

ORIC Pharmaceuticals last released its quarterly earnings data on March 11th, 2024. The reported ($0.49) EPS for the quarter, hitting the consensus estimate of ($0.49). ORIC Pharmaceuticals has generated ($1.96) earnings per share over the last year (($1.96) diluted earnings per share). Earnings for ORIC Pharmaceuticals are expected to decrease in the coming year, from ($1.75) to ($1.93) per share. ORIC Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 13th, 2024 based off prior year's report dates.

ORIC Pharmaceuticals Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/13/2024
Estimated)		------- 
3/11/2024-($0.49)($0.49)-($0.49)--
11/6/2023Q3 2023($0.46)($0.44)+$0.02($0.44)--
8/10/2023Q2 2023($0.58)($0.50)+$0.08($0.50)--
5/8/2023Q1 2023($0.54)($0.53)+$0.01($0.53)--
3/16/2023Q4 2022($0.56)($0.52)+$0.04($0.52)--
11/7/2022Q3 2022($0.55)($0.63)($0.08)($0.63)--
8/11/2022Q2 2022($0.60)($0.51)+$0.09($0.51)--
5/9/2022Q1 2022($0.57)($0.59)($0.02)($0.59)--  
3/21/2022Q4 2021($0.61)($0.58)+$0.03($0.58)--    
11/8/2021Q3 2021($0.58)($0.47)+$0.11($0.47)--
8/10/2021Q2 2021($0.49)($0.57)($0.08)($0.57)--
5/6/2021Q1 2021($0.48)($0.45)+$0.03($0.45)--  

ORIC Pharmaceuticals Earnings - Frequently Asked Questions

When is ORIC Pharmaceuticals's earnings date?

ORIC Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 13th, 2024 based off last year's report dates. Learn more on ORIC's earnings history.

Did ORIC Pharmaceuticals beat their earnings estimates last quarter?

In the previous quarter, ORIC Pharmaceuticals (NASDAQ:ORIC) reported ($0.49) earnings per share (EPS) to hit the analysts' consensus estimate of ($0.49). Learn more on analysts' earnings estimate vs. ORIC's actual earnings.

How much profit does ORIC Pharmaceuticals generate each year?

ORIC Pharmaceuticals (NASDAQ:ORIC) has a recorded net income of -$100.70 million. ORIC has generated -$1.96 earnings per share over the last four quarters.

What is ORIC Pharmaceuticals's EPS forecast for next year?

ORIC Pharmaceuticals's earnings are expected to decrease from ($1.75) per share to ($1.93) per share in the next year.


More Earnings Resources from MarketBeat

Related Companies:
Earnings Tools:
Earnings By Country:
Latest Articles:
This page (NASDAQ:ORIC) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
Healthcare Takes A Big Step Forward With The Help Of AI
The Bull Report
Biden’s $374B Giveaway Into This Sector
DTI
The #1 Crypto for 2024
InvestorPlace
He Is Giving Away Bitcoin
Crypto Swap Profits
Urgent alert: open this for a huge profit potential
Timothy Sykes
My biggest AI fear
Paradigm Press
How Biden has already won 2024
Porter & Company
Options trading has suddenly become more reliable.
Eagle Publishing